Stay updated on Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page.

Latest updates to the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page gains a recruitment status note stating no participants are being sought and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) with an updated revision label. It also standardizes the Intervention/Treatment label by removing the space around the slash.SummaryDifference0.4%

- Check15 days agoChange DetectedThe page's revision indicator was updated from v3.5.4 to v3.5.5, replacing the previous revision tag. This reflects a new page version for internal tracking.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a new build/version of the page's content rather than changes to the study data.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, indicating a new page build. This change does not modify any study data, eligibility criteria, or results.SummaryDifference0.1%

- Check58 days agoChange DetectedA publication citation under Study Publications was updated, changing how the same article is referenced (publication timing/formatting) from one citation variant to another.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

Stay in the know with updates to Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page.